BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Tyrphostin Ag 1478

RTKI cpd [Supplementary Concept] preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors

4+ PubMed studies analyzed · Evidence Score: 17.2

Research Domains

Tyrphostin Ag 1478 has been studied across 6 research domains including 🔬 Inflammation, 🧘 Stress & Anxiety, 🔬 Oncology, 🫁 Liver & Detox, 🫘 Kidney. The primary research focus is 🔬 Inflammation with 25% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tyrphostin Ag 1478, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Afatinib
24 shared targets
darapladib
14 shared targets
ibrutinib
16 shared targets
2-Methoxyestradiol
12 shared targets
neflamapimod
13 shared targets
masitinib
13 shared targets
Dequalinium
15 shared targets
Dasatinib
33 shared targets
Vemurafenib
13 shared targets
Iodoacetamide
13 shared targets
Loading evidence profile...

This evidence profile for Tyrphostin Ag 1478 is generated deterministically from 4 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.